Proposed Legislation: Comprehensive Ban on Phytoestrogenic Substances (Flax, Soy, Estrogenic Essential Oils and Herbs) and Mandatory Warning Labels
Introduction: The Urgent Need to Address Phytoestrogens
Phytoestrogens, plant-based forms of estrogen, directly elevate estrogen levels in the body, leading to severe hormonal imbalances with profound health and societal consequences. Unlike synthetic estrogens or xenoestrogens such as Atrazine, phthalates, BPA, etc., phytoestrogens are consumed in large quantities daily, amplifying their disruptive impact. A single gram of phytoestrogens is 1 billion times stronger than a nanogram of these synthetic compounds, making their pervasive presence in food and products a significant threat to public health.
The introduction of soy and flax into the modern diet has created a silent public health crisis, as these substances are marketed as âhealth foodsâ despite their estrogenic effects. This bill proposes a comprehensive ban on phytoestrogenic substances, mandatory warning labels for whole-food sources, and public education campaigns to mitigate their widespread and damaging effects on individual health, fertility, and societal stability. Immediate action is necessary to safeguard future generations and restore hormonal balance in the population.
Section 1: Regulation of Phytoestrogenic Substances Flax and Soy
A. Prohibition on Phytoestrogenic Substances Flax and Soy
This bill seeks to prohibit the use, sale, and inclusion of phytoestrogenic substances and their derivatives in all food products, dietary supplements, and animal feed. Specifically, the following items are banned:
Flaxseed
Flax oil
Soy
Soy lecithin
Soy emulsifiers
Soya
Soy protein
Soy oil
Soy formula
All their derivatives
B. Mandatory Warning Labels for Whole Food Phytoestrogen Sources
Products containing whole food forms of phytoestrogens, such as tofu, tempeh, edamame, and flaxseed, must display clear warning labels.
Required Label Text:
WARNING: This product is a phytoestrogen, which has been linked to an increased risk of PMS, PCOS, menopause symptoms, fibroids/masses, infertility, pregnancy loss, breast and uterine cancer, early puberty, gender dysphoria, feminization of boys, masculinization of girls, low testosterone, and sterility.
C. Rationale and Supporting Evidence
a. Public Health Concerns:
Phytoestrogens are a plant-based form of estrogen that directly increases estrogen levels in the body because they are bio-identical to endogenous estrogen, contributing to hormonal imbalances that impact fertility, early puberty, gender identity confusion, the feminization/masculinization of children, excess estrogen levels in men and women along with breast and uterine cancer.
The concept that phytoestrogens âblockâ is a medical fallacy and not supported by medical evidence.
Scientific studies have demonstrated:
Turtle eggs exposed to phytoestrogens develop exclusively female offspring.
Japanese researchers altered catfish biology, increasing weight by turning all fish female with soy feed.
Transplacental transfer of soy compounds from mother to child has been documented, exposing fetuses to phytoestrogens in utero.
b. Hormonal Impact on Society:
Introduction of Soy in the Late 1970s:
The widespread inclusion of soy in the American food supply began in the late 1970s, introducing significant levels of phytoestrogens into everyday diets. This shift has directly contributed to widespread hormonal imbalances with profound societal effects.
Breast Cancer Statistics:
Breast cancer rates have increased significantly since soyâs introduction. By 1992, the rate rose from 1 in 11 women (1980) to 1 in 8, with 80% of breast cancer cases fueled by estrogen as identified in pathology reports or biopsy.
In men, breast cancer rates have risen by 1% annually since 1979, with researchers often citing âunknown reasons.â
The promotion of soy as a health food has significantly influenced dietary trends in other countries. For example, in Japan, breast cancer has now become the leading type of cancer among women, highlighting the global impact of estrogenic substances in diets.
Testosterone Decline:
Male testosterone levels have been decreasing at an average rate of 1% annually since 1980, amounting to a 25% decline over the past 40 years.
Sperm counts have fallen by 52%, and at the current trajectory, sperm counts may reach zero by 2045, leading to widespread infertility.
Increased Estrogen Exposure:
A single cup of soy milk delivers an estrogenic dose equivalent to one birth control pill, while Πcup of flaxseed equals 20 pills.
Soy products, heavily marketed as health foods, are now a staple in many diets, contributing to high daily phytoestrogen exposure. For example, an Impossible Burger contains 44 mg of estrogenâ18 million times more than a Whopper, which contains only 2.5 ng.
3. Economic and Societal Costs:
a. Early Puberty and Hormonal Interventions: Early puberty affects 44% of girls aged
b. 7-8, with 14.3% of Black girls developing breasts or pubic hair by the age of 6. Of these, 15% require intervention, including the use of puberty blockers. Over the last five years, 4,780 adolescents have started puberty blockers, reflecting a skyrocketing increase in such interventions.
c. Rising Gender Dysphoria and LGBT Identification: Gender dysphoria rates have risen dramatically, with a 4,000% increase in transgender identification among girls in England over the last decade. Similarly, in the U.S., the number of transgender children seeking treatments or surgeries nearly tripled, from 42,000 in 2017 to 121,000 by 2021. These trends align with broader societal shifts, including:
The percentage of individuals identifying as LGBT rising from 1.2% in 1990 to 5.5% in 2011-2013, and further to 7.1% by 2022.
Reports of same-sex experiences among women aged 16-44 increasing from 4% in 1990 to 16% by 2010.
The widespread introduction and consumption of phytoestrogens, substances known to disrupt hormone balance, may play a significant role in these patterns, influencing both gender identity and sexual behaviors.
4. The Influence of Estrogen on Obesity
The inclusion of soy and flax in animal feed is primarily intended to promote weight gain. Estrogen compounds found in these substances have been linked to increased fat accumulation. PhGiven the growing concerns about obesity rates in America, supporting the ban on soy and flax in animal feed is an important step toward addressing this issue.
5. The Infertility Epidemic
This legislation acknowledges that the removal of xenoestrogens, such as Atrazine, Phthalates, pesticides, etc., alone will not reverse the ongoing decline in fertility. It is crucial to address phytoestrogens as the primary contributing factor in order to effectively improve fertility rates.
Profit-Driven Growth
a. Approximately $4.5 trillion is spent annually on healthcare costs in the United States, with 80% of these expenditures linked to chronic illnesses, including hormone-related disorders. Despite this significant investment, the United States has the lowest life expectancy among all developed countries, highlighting the urgent need for effective interventions to address the growing prevalence of chronic conditions.
b. The global market for sex reassignment surgery is projected to exceed $1.5 billion by 2026, with an annual growth rate of 24.5%. This rapid expansion reflects the increasing demand for such procedures and the financial incentives tied to the proliferation of hormone-disrupting substances like phytoestrogens. These economic forces compound the societal and public health challenges, creating
c. In 2023, the U.S. breast cancer drug market generated $28.1 billion in sales, with CDK4/6 inhibitors and HER2-targeting agents leading the market. The market is projected to experience significant growth, reaching an estimated $78.61 billion by 2033.
d. Chronic health problems arenât just creating a flow of income for corporations; they are financially crippling individuals. Medical debt is the number one cause of bankruptcy in the United States, locking families into a lifetime of debt and despair. RFK Jr. said, âThere is nothing more profitable in our society today than a sick child because all these entities are making money on the insurance companies, the hospital, the medical cartel, the pharmaceutical companies have a lifetime annuityâŠthey want them sick for the rest of their lives.â
The silent epidemic of phytoestrogens, quietly infiltrating our food, products, and supplements ensures that we will never fully recover. This widespread exposure to phytoestrogens is silently altering the hormonal balance of future generations, perpetuating a cycle of illness and financial dependency that keeps us trapped.
Section 2: Regulation of Phytoestrogenic Essential Oils and Medicinal Herbs
Herbs and essential oils are effective because they are medicineâ herbal medicinals with proven therapeutic properties. While often marketed as natural remedies, they are in fact powerful medicinal substances that carry inherent risks when misused or overused. Americanized herbal medicine has been overmedicated, misdiagnosed, and misused, deviating from its traditional applications and therapeutic benefits.
These risks are not always disclosed to the public, particularly in Western medicine, where the understanding of the potential side effects has been limited. Many supplement companies have taken advantage of loose regulations, failing to properly inform both doctors and the public about the possible side effects of herbs and essential oils. In the rush to profit from the booming health and wellness market, these companies have neglected due diligence in educating consumers about the dangers of misusing these potent substances. This lack of information has led to widespread misconceptions that herbs and essential oils are inherently safe simply because they come from plants.
Both doctors and companies often claim that herbs and essential oils are safe because they come from plants, implying that their natural origins automatically make them harmless. However, this is a misleading assumption. Pharmaceutical companies have long used plant compounds to create drugs, such as wild yam, which contains estrogen, the precursor to The Birth Control Pill. While these plant compounds were used to develop life-saving medications, they are not automatically âsafeâ in their raw, unregulated form. The same compounds that are carefully controlled and dosed in pharmaceutical products can have dangerous effects if used improperly or without proper knowledge.
This widespread use of supplements, many of which contain phytoestrogenic substances, has further contributed to the increasing public health concerns surrounding hormone disruption. The unregulated promotion of these products has led to a rise in cases of hormonal imbalances, toxic reactions, and long-term health consequences.
Profit-Driven Growth in the Supplements and Essential Oils Industries
a. The global supplements market was valued at $165.71 billion in 2022, with the U.S. supplement market accounting for $35.6 billion. According to a 2023 consumer survey, 74% of adults use supplements, with 55% being regular users.
b. According to Future Market Insights (FMI), the revenue of the herbal medicinal products market was $199.07 billion in 2023 and is expected to reach $417.99 billion by 2033. Market Research Future (MRFR) forecasts the herbal medicine market will grow at a compound annual growth rate (CAGR) of 11.34% from 2024 to 2032.
c. The global essential oils market was valued at USD 23.74 billion in 2023 and is projected to grow at a CAGR of 7.6% from 2024 to 2030. This growth is driven by increasing demand from key end-use industries, including food & beverage, personal care & cosmetics, and aromatherapy.
Essential oils and herbs have been used traditionally for thousands of years, particularly in Chinese medicine, where they are considered an intricate form of pharmacology. These natural substances are often marketed as safe and beneficial, but their concentrated nature and the lack of proper regulation present significant risks to public health. While herbs contain multiple active properties that enhance their effectiveness, they can also lead to harmful side effects. Not all herbs are suitable for every body type, and many are contraindicated for use in children, pregnant women, or breastfeeding mothers due to the severe side effects they can cause in these sensitive populations.
In the past, local herbalists would diagnose and recommend herbs to ensure their safety and minimize risks. However, in the United States, many of these herbs and essential oils are freely available over the counter, without sufficient guidance or oversight. This widespread availability has led to misuse and has contributed to hormonal disorders, respiratory issues, and other health concerns that could have been prevented with proper training and education. Additionally, in America, Chinese medical doctors/herbalists must complete four years of herbal studies to obtain a medical license. However, M.D.s, N.D.s, and D.C.s often lack formal training in herbs, yet they prescribe them without fully understanding the potential side effects, contraindications, or harmful combinations, as well as the individuals who may be at risk due to these contraindications. Furthermore, when combined with modern health practices, the use of these potent substances requires expertise to avoid adverse effects. If they were properly educated, they would understand that herbs are not commonly given to pregnant women, breastfeeding mothers, or children. This is one of the key reasons why the public is experiencing widespread health issues, especially children.
As a result, the need for strict laws and regulations has become undeniable. These products require careful oversight to ensure safety and mitigate their negative effects. To protect the public and healthcare providers, it is essential to impose stricter regulations on the sale and marketing of essential oils and herbal supplements. These substances are not mere plants that are automatically safe; their medicinal properties, if left unchecked, can lead to serious health issues. It is imperative that both consumers and doctors are properly informed about the potential side effects and risks, and that products are not marketed without thorough safety testing and transparency.
These trends underscore the urgent need for regulation of phytoestrogenic substances to prevent further health complications.
A. Prohibition in Baby, Pregnancy, and Breastfeeding Products
Lavender and tea tree oils, as concentrated phytoestrogens, are banned from inclusion in all baby products, pregnancy products, and breastfeeding products, including organic formulations. Scientific evidence demonstrates their significant risks, including:
In Boys:
Early puberty and feminization.
Breast masses.
Anxiety, weight gain, and mood swings.
Low testosterone, muscle weakness, and small organ size.
Potential sterility.
In Girls:
Early puberty and masculinization.
Severe cases of PCOS and PMDD.
Breast masses and early menstruation.
Depression, mood swings, and weight gain.
Possible infertility.
B. Mandatory Warning Labels on Phytoestrogenic Essential Oils and Herbal Products
All skincare, household products, dietary supplements, and essential oil packaging containing phytoestrogenic essential oils or herbal medicinesâwhether labeled as organic or naturalâmust display mandatory warning labels.
Required Label Text:
WARNING: This product is a phytoestrogen, which has been linked to an increased risk of PMS, PCOS, menopause symptoms, fibroids/masses, infertility, pregnancy loss, breast and uterine cancer, early puberty, gender dysphoria, feminization of boys, masculinization of girls, low testosterone, and sterility.
Mandatory labels must be added to all essential oils and company labels for products intended for children:
Required Label Text:
WARNING: This product is a phytoestrogen, which has been linked to an increased risk of early puberty, gender dysphoria, feminization of boys, masculinization of girls, and breast masses. For short-term use only to treat illness, and must be properly diluted.
Essential Oils Requiring Warning Labels:
Lavender
Aniseed
Basil
Chamomile
Clary Sage
Coriander
Cypress
Evening Primrose
Fennel
Frankincense
Geranium
Oregano
Peppermint
Rose
Rosemary
Sage
Sandalwood
Tea Tree
Thyme
Herbs Requiring Warning Labels
Exemptions for Traditional Chinese Medical Herbal Formulas and Herbs
Ashwagandha/Indian Ginseng
Asian Ginseng
Astragalus/Huang Qi
Bitter Melon Seeds
Black Cohosh
Black Seed
Burdock Root
Calendula
Chasteberry/Vitex
Dandelion
Dong Gui
Fennel Seeds
Fenugreek
Fo-Ti/Ye Jiao Teng
Fructus Cnidii Monnieri
Heartwood
Hemp/CBD (Cannabis)
Golden Root/Goldenseal or Siberian Rhodiola
Hops
Kudzu Root
Lavender
Licorice
Neem Oil
North American Ginseng
Milk Thistle
Mistletoe
Moringa Seeds
Mucuna
Prickly Pear
Red Clover
Red Pine Needle
Rhubarb
Saw Palmetto
Semen Cassiae
Siberian Rhodiola
Stinging Nettle
Tu Fu Ling
Turmeric
White Kwao Krua
Xiang Fu
Yu Jin
C. Risks and Misuse of Essential Oils and Herbal Medicines
Additional Risks and Side Effects of Essential Oils and Herbs Beyond Hormonal Disruption: Demonstrating the Powerful Medicinal Effects and Potential Dangers
Essential oils and herbs, while often promoted for their therapeutic benefits, carry significant risks when misused or overused. Their potent medicinal properties, though beneficial in certain contexts, can also lead to adverse health effects, including hormonal disruptions, toxicity, and interference with medications.
-
High Concentration of Pesticides
-
Toxicity and Organ Damage
Certain herbs, when consumed in excessive amounts or over extended periods, can cause toxicity and damage vital organs:
-
Allergic Reactions and Sensitivities
-
Interactions with Medications
-
Environmental Impact
The production of essential oils and herbal medicines is resource-intensive, leading to environmental harm:
For example, it takes 10,000 roses to produce just one ounce of rose essential oil.
Overharvesting can deplete plant populations, cause environmental degradation, and threaten biodiversity.
-
Photosensitivity
-
Risks for Sensitive Populations
Certain groups, such as pregnant women, children, and elderly individuals, are particularly vulnerable to the risks posed by herbs and essential oils:
-
Overuse and Misuse
-
Vaporizing and Respiratory Issues
-
Lack of Regulation
Although essential oils and herbal medicines have been used for centuries, their concentrated nature, pesticide contamination, and potential for misuse demand rigorous regulation. These substances must be used carefully, with proper labeling, sourcing, and education. Stricter oversight is essential to mitigate risks and protect public health and the environment, especially for vulnerable populations such as children, pregnant women, and breastfeeding mothers.
Section 3: Regulation of Phytoestrogens in Bio-Identical Hormone Therapies
Bio-identical hormones are increasingly used to balance hormone levels in both men and women, especially for conditions like menopause, low testosterone, fertility issues, and hormonal imbalances. However, they are phytoestrogens, and phytoestrogens are bio-identical. The term âbio-identicalâ is often used to confuse patients, leading them to believe these hormones are inherently safer or more natural, when in reality, they may still pose significant health risks. The term bio-identical actually means âsimilar chemical function.â These hormones are chemically identical or âbio-identicalâ to those produced naturally by the body, and their use has risen significantly due to the perception that they are safer and more natural than synthetic hormones. However, the use of bio-identical hormones, particularly in hormone replacement therapies, has raised significant concerns regarding the inclusion of phytoestrogens.
Doctors assert that phytoestrogens act as xenoestrogen blockers, yet they often prescribe phytoestrogen-based products, such as wild yam cream, for women. Bio-identical hormones are derived from wild yam cream. So, the question arisesâdo phytoestrogens block or treat?
The presence of phytoestrogens in certain bio-identical hormone therapies, such as those derived from soy, flax, and sesame oils, can dramatically affect the efficacy of these treatments. Phytoestrogens interfere with the delicate balance of testosterone and progesterone therapies, potentially leading to reduced effectiveness and unintended hormonal disruptions. The inclusion of these plant-based compounds compromises the purity of hormone injections, which are intended to provide precise hormonal support, and can increase the risk of hormonal imbalances, low testosterone, breast cancer, and reduced fertility and sterility.
Profit-Driven Growth in the Bio-Identical Hormone Market:
a. The global bio-identical hormone market is currently valued at $2.23 billion and is projected to reach $3.70 billion by 2032, growing at a CAGR of 5.70%.
This growth reflects the increasing adoption of bio-identical hormones for both medical and wellness purposes, highlighting a significant shift toward personalized hormone therapies. However, as the market continues to expand, it is essential to recognize the potential risks posed by certain ingredients, particularly phytoestrogens, which can interfere with the effectiveness and safety of these treatments. As the market grows, it is critical that stricter regulations are implemented to ensure the safety and efficacy of bio-identical hormone products, safeguarding consumers from the risks associated with hormone disruption.
A. Banning of Phytoestrogens in Progesterone and Testosterone Hormone Injections
To ensure the effectiveness and safety of bio-identical hormone therapies, the use of phytoestrogens, particularly in testosterone and progesterone injections, must be strictly regulated. Oils, containing phytoestrogen, decreases the therapeutic effects of the testosterone or progesterone, and may lead to unwanted side effects such as hormonal disruption and feminizing effects in men, like breast tenderness and masses which occur with estrogen dominance. The purity of hormone therapy is critical to its success, and the presence of phytoestrogens undermines its intended purpose.
Flax
Soy
Sesame
Garbanzo/Chickpea
Testosterone:
Sperm counts have fallen by 52%, and at the current trajectory, sperm counts may reach zero by 2045, leading to widespread infertility.
Men use testosterone to increase their testosterone levels, but if their injections contain phytoestrogens, they cannot effectively raise their testosterone levels, compromising their health and virility.
Progesterone:
The leading cause of infertility is estrogen dominance.
Women use progesterone injections to increase progesterone levels for fertility. However, if phytoestrogens are present in the progesterone, the treatment becomes ineffective.
B. Banning of Phytoestrogens in Progesterone in Creams, Oils, Gels and Pills
To ensure the effectiveness and safety of bio-identical hormone therapies, the use of phytoestrogens, particularly in progesterone creams, oils, gels and pills, must be strictly regulated. Products containing phytoestrogens dilute the therapeutic effects of the progesterone and may lead to unwanted side effects, such as hormonal disruption. The purity of hormone therapy is critical to its success, and the presence of phytoestrogens undermines its intended purpose.
Progesterone is derived from wild yam cream but is formulated to remove the estrogenic effects. Progesterone that is solely progesterone, is labeled USP progesterone.
Most popular phytoestrogens found in USP progesterone
Lavender
CBD
Black Cohosh
Primrose
DHEA
Burdock root
Red clover
Licorice
Wild Yam or Yam as an added ingredient to USP Progesterone
There may be additional phytoestrogens present in progesterone cream, which could further contribute to hormonal imbalances. For more information, please refer to the additional essential oils and herbs discussed in Section 2.
C. Warning Labels for Wild Yam Cream and Informed Consent for Bio-Identical Estrogen
Wild yam cream, marketed as bio-identical estrogen, is another product that contains phytoestrogens and can have significant health risks. Despite being promoted as a natural alternative to synthetic estrogen, wild yam cream is a plant-based estrogen that increases estrogen levels and can disrupt hormonal balance. Therefore, it should be used with caution. Mandatory warning labels must be applied to these products to inform consumers of the potential risks associated with their use.
Due to the risk of breast and uterine cancer, doctors must inform patients of this risk, ensuring they sign an acknowledgment that they have been informed and consent to the risks.
Required Label Text for Wild Yam and Estrogen Creams Sold Over the Counter:
WARNING: This product is a phytoestrogen, which has been linked to an increased risk of PMS, PCOS, menopause symptoms, fibroids/masses, infertility, pregnancy loss, breast and uterine cancer.
Required Informed Consent at Doctorsâ Offices for Bio-Identical Estrogen:
WARNING: This product is a phytoestrogen, which has been linked to an increased risk of PMS, PCOS, menopause symptoms, fibroids/masses, infertility, pregnancy loss, breast and uterine cancer.
D. Hormonal Impact on Society
The widespread use of bio-identical hormones has had a profound impact on society, particularly in terms of breast cancer and fertility. It is important to note that 80% of breast cancer cases are estrogen-fueled, as identified in pathology reports and biopsies. The introduction of phytoestrogens into bio-identical hormone therapies has compounded this issue, as these compounds mimic estrogen in the body, increasing the risk of estrogen-dependent cancers.
Bio-identical hormones are essential for maintaining hormone balance, particularly in treating conditions like PMS, PCOS, and menopause. However, the addition of phytoestrogens from plants such as soy and flax compromises the purity of these therapies, reducing their effectiveness and increasing health risks. The hormonal effects of these plant-based compounds include lower testosterone levels in men and disrupted menstrual cycles in women, further complicating their use in hormone therapy.
As the bio-identical hormone market continues to expand, it is crucial that stricter regulations are implemented to ensure the safety and effectiveness of these therapies, protecting consumers from the unintended consequences of hormone disruption.
Section 4: Products: Recognizing Phytoestrogenic Effects of CBD, THC, and Hemp Seed
A. Warning Labels for Phytoestrogenic CBD, THC, and Hemp Seed
With the increasing popularity of CBD (Cannabidiol), THC (Tetrahydrocannabinol), and hemp seeds, it is crucial to recognize that these compounds are phytoestrogens. When ingested or applied topically, CBD, THC, and hemp seeds significantly increase estrogen levels in the body because phytoestrogens bind to estrogen receptors and raise estrogen levels. This mechanism is stronger when compared to smoking, as the absorption and effects are more direct through ingestion or topical application.
While CBD, THC, and hemp seeds are commonly used for their therapeutic effects, such as pain relief, anxiety management, and nutritional benefits, their ability to raise estrogen levels requires caution. Elevated estrogen levels can lead to hormonal imbalances, especially in individuals with hormone-sensitive conditions.
Given the potential for hormonal disruption, mandatory warning labels must be applied to CBD, THC, and hemp seed products to inform consumers of the potential risks. This is particularly important for vulnerable groups, such as pregnant women, breastfeeding mothers, and individuals with estrogen receptor positive breast cancer.
Required Label Text for CBD, THC, and Hemp Seed Products:
WARNING: This product is a phytoestrogen, which has been linked to an increased risk of PMS, PCOS, menopause symptoms, fibroids/masses, infertility, pregnancy loss, breast and uterine cancer, early puberty, gender dysphoria, feminization of boys, masculinization of girls, low testosterone, and sterility.
Profit-Driven Growth in the Cannabidiol (CBD) Market
a. In the United States, cannabidiol (CBD) products generated sales of approximately 5.3 billion U.S. dollars in 2021. By 2026, sales of CBD products are projected to reach nearly 16 billion U.S. dollars.
As the CBD, THC, and hemp seed markets continue to grow, it is essential that more stringent regulations be put in place to ensure these products are safe and effective, safeguarding consumers from the unintended risks associated with hormone disruption.
Section 5: Enforcement and Public Awareness Campaign
Public education campaigns will emphasize the risks associated with phytoestrogens and promote alternative, hormone-safe foods and products.
A: Urgency of Action
This legislation recognizes that the removal of xenoestrogens, Atrazine alone will not reverse the current trends in fertility decline, hormone disruption, and societal gender imbalances. Addressing phytoestrogens as a primary factor is essential to safeguard public health, preserve biological integrity, and protect future generations from irreversible harm.
About The Authors
This proposal was formulated by the leading researchers in phytoestrogens and thermography. William Hobbins, MD, breast surgeon, was one of the first doctors to warn the public about the dangerous side effects of soy in the 1980s, using breast thermography. In 2010, Dr. Hobbins and Dr. Sellens Bronson published medical evidence through breast thermography proving that flax increased the risk of breast cancer. In their first publication in 2013, Breast Cancer Boot Camp: Dr. Hobbinsâs Breast Thermography Revolution, they published medical evidence proving that bio-identical estrogen, or wild yam cream, dramatically increased the risk of breast cancer.
All references can be viewed on Amazon in the following two books:
*Soy Boys: The Rise in Low Testosterone & the Feminization of Men Due to Phytoestrogens
*The Breast Thermography Revolution: Bootcamp for an Estrogen-Free Life (or) on a PDF at estrogen-free.com on the Lifestyle page.
This proposal was submitted by: Wendy Sellens a Chinese medical doctor, breast thermologist, thermography and hormone researcher and protĂ©gĂ© to William B. Hobbins M.D., one of the original mammography researchers, leading researcher in thermography and renowned breast surgeon. She is following her mentorâs pioneering spirit and is president of the consumer advocacy group the Womenâs Academy of Breast Thermography, president of The Pink Bow Breast Thermography Research and Education non-profit, author of eight books including âBreast Thermography Revolutionâ and creator of the Estrogen FreeÂź lifestyle to dramatically reduce risk of breast cancer and hormonal disorders in the entire family.
